Our findings indicated that deficiency in AAT results in a diminished capacity to inhibit the proteolytic processing of C3 to C3d, suggesting a potential role for complement activation in the pathogenesis of AATD-related disease [19]. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.